Novavax has inked another settlement for a past COVID-19 vaccine supply deal. | Novavax has inked another settlement for a ...

On November 1, Novavax, Inc. (NASDAQ:NVAX) and the U.K. Health Security Agency, representing the U.K. Secretary of State for ...

Novavax said on Tuesday that it has entered into a termination and settlement agreement with the UK Health Security Agency ...

the companies can individually develop their own flu-COVID vaccines and other products, it said in an e-mailed statement. "Fundamentally this doesn't seem to have a direct impact on Novavax's ...

getting the combination and standalone flu products to market. Novavax hopes to then strike licensing deals with other pharmaceutical companies for those vaccines, so it can turn its attention to ...

it appears to be a setback for the biotech company, which is scrambling to bring new products to market as demand for its Covid vaccine plummets worldwide. Novavax on Wednesday said the Food and ...

the companies can individually develop their own flu-COVID vaccines and other products, it said in an e-mailed statement. “Fundamentally this doesn’t seem to have a direct impact on Novavax ...

and if approved by the Medicines and Healthcare products Regulatory Agency (MHRA) a large proportion of those supplies will be manufactured at Novavax’ UK factory in Billingham, Stockton-on-Tees.

In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three vaccines available in the U.S.

ASML extends losses after cutting sales guidance, Nvidia stock edges higher, and third-quarter earnings at Morgan Stanley top ...

With flu season underway and new, developing COVID-19 strains, health professionals continue to stress the importance of receiving an updated vaccine. On Oct. 23, the Centers for Disease Control ...